Recent Business Highlights

India & Emerging Markets: Growth driven by patient centric initiatives 2018 2021 • India • Focus on mega brands expansion Improvement in new launch productivity Step-up in Chronic and Super-specialty therapies • Portfolio augmentation and productivity improvement • • Strategic business development and M&A efforts • Differentiated assets in relevant therapies Focus on new growth avenues [a] Institution / Corporate hospitals; [b] OTC and Nutritionals EM • . Focus on mega brands expansion / improvement in field force productivity Launch of Biosimilar products in existing markets Leveraging the Complex generics / Biosimilar portfolio, across markets Increase depth in lead geographies of Russia, Brazil & China Expanding presence in new markets Selective business integration for OTC / differentiated assets Augment the capacities by establishing local manufacturing capabilities 19

View entire presentation